Stay updated on ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    A banner about NIH website updates and a terminology transition was removed. The page continues to display a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-07T11:30:21.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-31T10:45:41.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A notice appears above the page announcing NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T12:09:41.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:11:21.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T13:47:46.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the previous study record content. A minimal header shows '403' and a 'Home' button, with a site revision note 'Revision: v3.7.0' visible in the footer.
    Difference
    20%
    Check dated 2026-09-19T18:42:29.000Z thumbnail image

Stay in the know with updates to ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.